Author Topic: Breaking News - US Patent Issued to Merck Sharp & Dohme, Istituto Di Ricerche Di Biologia Molecolare P. Angeletti on Feb. 19 for "HCV NS3 Protease Inhibitors" (American, Italian Inventors)  (Read 655 times)

MikeLigalig.com

  • FOUNDER
  • Webmaster
  • *****
  • Posts: 33285
  • Please use the share icons below
    • View Profile
    • Book Your Tickets on a Budget
US Patent Issued to Merck Sharp & Dohme, Istituto Di Ricerche Di Biologia Molecolare P. Angeletti on Feb. 19 for "HCV NS3 Protease Inhibitors" (American, Italian Inventors)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 8,377,873, issued on Feb. 19, was assigned to Merck Sharp & Dohme Corp. (Rahway, N.J.) and Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. (RomeHCV NS3 Protease Inhibitors" was invented by Nigel J. Liverton (Harleysville, Pa ... (Publication: US Fed News Service, Including US State News)

Source: US Patent Issued to Merck Sharp & Dohme, Istituto Di Ricerche Di Biologia Molecolare P. Angeletti on Feb. 19 for "HCV NS3 Protease Inhibitors" (American, Italian Inventors)

Linkback: https://tubagbohol.mikeligalig.com/index.php?topic=69240.0
John 3:16-18 ESV
For God so loved the world, that he gave his only Son (Jesus Christ), that whoever believes in him should not perish but have eternal life. For God did not send his Son into the world to condemn the world, but in order that the world might be saved through him. Whoever believes in him is not condemned, but whoever does not believe is condemned already, because he has not believed in the name of the only Son of God.

👉 GET easy and FAST online loan at www.tala.com Philippines

Book tickets anywhere for planes, trains, boats, bus at www.12go.co

unionbank online loan application low interest, credit card, easy and fast approval

Tags: